medline.ch Respirationstrakt Neoplasie

	MiR-4701-3p predicts prognosis of non-small cell lung cancer and regulates cell biological behaviors. Hereditas Hao Z, Sun Y, Xu G, Cao J, Pan Y. PMID: 41316500 [PubMed - as supplied by publisher]
	Neural regulation of lung cancer: from mechanisms to clinical implications. Eur J Med Res Xu L, Sun X, Yao Y, Fang H. PMID: 41316431 [PubMed - indexed for MEDLINE]
	Prophylactic cranial irradiation together with molecular subtyping in surgically resected small-cell lung cancer: a inverse-probability-of-treatment weighted cohort study. Respir Res Li R, Xiang Y, Yang L, Dong J, Wang W, Tang F, Bi N. PMID: 41316182 [PubMed - as supplied by publisher]
	Leveraging large language models to extract smoking history from clinical notes for lung cancer surveillance. NPJ Digit Med Luo I, Graber-Naidich A, Zhang M, Kaushik R, Nieda GM, Chen T, Gu B, Choi E, Ding VY, Gunturkun F, Satoyoshi M, Bhat A, Lee TY, Su CC, Ellis-Caleo TJ, Henry AS, Desai M, Backhus LM, Lui NS, Leung A, Neal JW, Kurian AW, Langlotz CP, Wakelee HA, Liang SY, Khan A, Han SS. PMID: 41315854 [PubMed]
	Cost-effectiveness of chest radiography using artificial intelligence for lung cancer screening in South Korea. Sci Rep Kim K, Kim JH, Shin J, Kim MS, Park SH, Chang JH, Han CH, Oh SN. PMID: 41315843 [PubMed - as supplied by publisher]
	Cellular dynamics in cerebrospinal fluid unveils the key regulators of intracranial response to immune checkpoint inhibitors in NSCLC brain metastases. J Immunother Cancer Li YS, Lai W, Yin K, Tu HY, Li L, Lin SH, Li P, Zhou DX, Guo WB, Yang JJ, Zhou Q, Zhong WZ, Zhang XC, Jiang BY, Wang Z, Yang XN, Wang BC, Pan Y, Chen HJ, Xu CR, Zeng L, Chen ZH, Yan HH, Sun H, Dong ZY, Liu SM, Li Y, Luo OJ, Zheng MM, Wu YL. PMID: 41314983 [PubMed - indexed for MEDLINE]
	Categorizing immunotherapy resistance mechanisms in non-small cell lung cancer: how can we perform better? J Immunother Cancer van der Geest D, van Vliet A, Peeper DS, Haanen JBAG, Smit EF, Theelen WSME. PMID: 41314975 [PubMed - indexed for MEDLINE]
	Long-term outcomes of concurrent chemo-proton therapy for unresectable stage III non-small cell lung cancer: a Japanese national registry study. Radiother Oncol Iwata H, Murakami M, Maruo K, Nakamura M, Waki T, Nakamura M, Taguchi H, Inoue K, Araya M, Tatebe H, Satouchi M, Shimizu K, Hashimoto T, Harada H. PMID: 41314394 [PubMed - as supplied by publisher]
	Correlation between F-18 FDG PET/CT-derived metabolic parameters and PD-L1 expression in non-small cell lung cancer patients. Rev Esp Med Nucl Imagen Mol (Engl Ed) Kesim S, Ozulker F, Gul Gecmen G, Turan N. PMID: 41314286 [PubMed - as supplied by publisher]
	Radiotherapy for primary lung cancer: 2025 update. Cancer Radiother Khalifa J, El Houat Y, Thureau S, Darréon J, Antoni D, Blais E, Le Péchoux C, Lerouge D, Levy A, Lucia F, Marguerit A, Martin É, Pichon B, Pourel N, Giraud P, Riet FG. PMID: 41314143 [PubMed - as supplied by publisher]
	Letter to the Editor: "Prognostic Implications of Lymph Node Status in Non-Small-Cell Lung Cancer Patients Before and After Neoadjuvant Chemoimmunotherapy: A Multicenter Retrospective Study". Clin Lung Cancer Aphale P, Dokania S, Shekhar H. PMID: 41314018 [PubMed - as supplied by publisher]
	Health-related quality of life among anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC) patients treated with first- and next-generation ALK tyrosine kinase inhibitors (TKIs): a systematic review and meta-analysis. Qual Life Res Huang Y, Chu Q, Wang J, Zhang L. PMID: 41313568 [PubMed - as supplied by publisher]
	High Expression of Actin Binding Proteins Predicts Hematogenous Metastases in Non-Small Cell Lung Cancer. Asian Pac J Cancer Prev Kolegova ES, Kakurina GV, Sereda EE, Sidenko EA, Kostromitskiy DN, Dobrodeev AY, Kondakova IV. PMID: 41312930 [PubMed - indexed for MEDLINE]
	The tumor microenvironment in lung cancer: Heterogeneity, therapeutic resistance and emerging treatment strategies (Review). Int J Oncol Liu L, Yang L, Li H, Shang T, Liu L. PMID: 41312736 [PubMed - indexed for MEDLINE]
	Risk factor of pneumonitis resulting from thoracic chemoradiotherapy combined with immunotherapy in lung cancer: A meta-analysis and systematic review. iScience Ruan Y, Han J, Cao W, Long C, Yang A, Chen Z, Guo S, Zhang T. PMID: 41312390 [PubMed]
	Multi-omics integration identifies ASPH and PTTG1 as potential causal drivers of lung adenocarcinoma progression and immune evasion. Front Immunol Yang K, Chen M, Wu Y, Duan W, Huang N, Zhao X, Cheng D. PMID: 41312363 [PubMed - indexed for MEDLINE]
	Community Perceptions of Executive Orders Impacting Lung Cancer Care, Research, and Mental Health. Int J Public Health Monestime S, Newton B, Fathi J, Hicks D, Millner L, Ambrose L, Proctor E, Estrin-Lebovic C, Granville C. PMID: 41312115 [PubMed - indexed for MEDLINE]
	Advances in the role of extracellular vesicles in circulating microRNA biomarker discovery for lung cancer. Front Cell Dev Biol Belkozhayev A, Al-Yozbaki M, Ashirbekov Y, Satken K, Abaildayev A, Yeleussizov A, Jainakbayev N, Sharipov K, Wilson CM. PMID: 41311647 [PubMed]
	Aberrant TTF-1 expression in metastatic colorectal adenocarcinoma mimicking primary lung cancer: a case report and review of diagnostic pitfalls. Diagn Pathol Tran NT, Van Thai N, Khuyen NT, Le LT, Khoa LTA. PMID: 41310725 [PubMed - as supplied by publisher]
	Hierarchical reasoning for lung cancer detection: from multi-scale perception to hypergraph inference with CR-YOLO. NPJ Digit Med Xu Z, Shen T, Ye C, Li Y, Zhao D, Zhang M, Cheng Y, Chai J, Jiang J, Xi J, Xu C, Chen W, Liu S. PMID: 41310134 [PubMed]

Artikel 1 - 20 / 155295

Seite 1 von 7765



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung